VenomAid

Rapid diagnosis of snakebite victims

Ο   Ο   Ο

We want to improve the treatment of snakebite victims globally by making rapid diagnosis of snakebite victims possible in the most affected countries in the world

 

Each year more than five million people are bitten by venomous snakes. Snakebite envenoming calls for rapid diagnosis and correct treatment to avoid death and disability

THE SNAKEBITE CRISIS →

 

VenomAid presents a solution to this problem: A cheap, easy-to-use, point-of-care device that provides a reliable diagnostic result within minutes

OUR SOLUTION →

“The syndromic approach requires a highly skilled technical staff. It is very complex.”

Dr. G. Alcoba

Geneve Universityhospital and Doctors without borders (MSF)

“A widespread use of a fast and easy-to-use diagnostic device could have an impact of about a third or higher in preventing morbidity and mortality of snakebite victims.”

Dr. A. Habib

Physician in Infectious and Tropical Diseases at Aminu Kano Teaching Hospital, Kano, Nigeria.

“Rapid diagnosis and identification of the perpetrating snake species is of vital importance for successful snakebite treatment.”

A. H. Laustsen

postdoc, leader of Tropical Pharmacology Lab, DTU, and co-founder of Biosyntia, Antag Therapeutics, Chromologics, Bactolife, VenomAb, og REBBLS

Our solution is

Effective

VenomAid is simple, easy to use and provides a quick determination of which snake is responsible for the bite, which is essential for early and correct treatment.

Fast

VenomAid provides a reliable diagnostic result within minutes of loading blood directly from the bite wound (or from a standard blood sample) onto the device.

Affordable

Because of its simplicity, small size and low material use, VenomAid is able to counter the needs of snakebite victims in developing countries by providing great affordability.

THE SNAKEBITE CRISIS


Snakebite is a medical emergency affecting more than 5 million people every year. This leads to 2.5 million envenomings, 125.000 fatalities, and over 400.000 cases of permanent sequelae such as amputations. Uncertainty about the snake responsible combined with a variable time course for development of symptoms make great demands on medical personnel. They have to make a quick assessment on whether there are signs of envenoming and choose the correct antivenom treatment. This often has to be done on the basis of inconclusive information, leading to unnecessarily high death rates among snakebite victims.

THE TEAM

 


Aleksander M. Haack

Aleksander M. Haack

Co-founder





Cecilie Knudsen

Cecilie Knudsen

Co-founder





Jonas A. Jürgensen

Jonas A. Jürgensen

Co-founder





Rasmus U. W. Friis

Rasmus U. W. Friis

Co-founder





Søren H. Dam

Søren H. Dam

Co-founder




 

Contact us

Contact Us

We would like to hear from you. Please send us a message by filling out the form below and we will get back with you shortly.